DR. MICHAEL TAHERY M.D. NPI 1346249539

NPI Details

DR. Michael Tahery, M.D. is a gynecology obstetrics gynecology in Los Angeles, CA with 36 years of experience. The provider is a physician who specializes in diagnosis, treatment, and management of patients with gynecologic conditions. Source: National Uniform Claim Committee DR. Michael Tahery, M.D. NPI is 1346249539. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF CALIFORNIA, IRVINE, CALIFORNIA COLLEGE OF MEDICINE
Graduation Year:1990

The provider's business location address is:

10884 SANTA MONICA BLVD STE 400
LOS ANGELES, CA
ZIP 90025-639
Phone: (818) 296-9499
Fax: (818) 548-0447

The NPI 1346249539 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The CLIA number assigned to this NPI record is 05D0940223 - practitioner other with a certificate type of Certificate of Compliance.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, vedolizumab, 1 mg (HCPCS:J3380)
• Injection, romosozumab-aqqg, 1 mg (HCPCS:J3111)
• Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1561)
• Injection, mepolizumab, 1 mg (HCPCS:J2182)
• Injection, inclisiran, 1 mg (HCPCS:J1306)
• Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
• Injection, omalizumab, 5 mg (HCPCS:J2357)
• Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
• Injection, tildrakizumab, 1 mg (HCPCS:J3245)
• Injection, benralizumab, 1 mg (HCPCS:J0517)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina (HCPCS:76830)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Screening test for presence of antibody (HCPCS:86403)
• Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Bacterial culture and colony count (HCPCS:87071)
• Bacterial culture for aerobic isolates (HCPCS:87077)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• Bacterial urine culture (HCPCS:87088)
• Screening test for pathogenic organisms (HCPCS:87081)
• Fungal culture (mold or yeast) (HCPCS:87102)
• Mycoplasma culture (HCPCS:87109)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Bacterial culture, any other source except urine, blood or stool, aerobic (HCPCS:87070)
• Bacterial colony count, urine (HCPCS:87086)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory (HCPCS:Q0091)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Automated urinalysis test (HCPCS:81003)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Dilation and scraping of uterus (HCPCS:58120)
• Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings (HCPCS:51784)
• Biopsy of lining of uterus and/or removal of polyp using an endoscope (HCPCS:58558)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• Electronic assessment of bladder emptying (HCPCS:51741)
• Diagnostic exam of uterus using an endoscope (HCPCS:58555)
• Cervical or vaginal cancer screening; pelvic and clinical breast examination (HCPCS:G0101)
• Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies (HCPCS:51729)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)

The enumeration date for this NPI number is 7/19/2005 and was last updated on 5/23/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.